ABSTRACT. The relation of the total cellular content of sialic acid to phenotypic expression of B16 mouse melanoma cells was examined by using phenotype-modifying reagents and more than 10 cloned cell lines with spontaneous phenotypic variations. The sialic acid content changed in a growth phase-dependent manner with a peak in the early log phase of growth. This peak completely disappeared when cells were treated with 5-bromodeoxyuridine (BrdU), suggesting its relation to quasi-normal phenotypes of the treated cells. BrdU treatment also reduced the cellular sialic acid content itself and resulted in the suppression of the activity of tyrosinase, the key enzyme for melanogenesis, and a considerable increase in cell-to-substratum adhesiveness. Treatment with theophylline, in contrast, markedly elevated the sialic acid content, which was accompanied by dramatic increments in tyrosinase activity and pigmentation as well as a slight increase in adhesiveness. The results show a correlation of sialic acid level with tyrosinase expression but not with cell adhesion. From comparison of spontaneous phenotypic variations, the correlation of sialic acid level with tyrosinase activity was confirmed, while there was only a slight correlation with adhesiveness. It is thus suggested that sialylation/desialylation, being reflected as variations in cellular sialic acid content, is implicated in melanoma cell differentiation in terms of tyrosinase expression.Sialic acid has been shown to play important roles in a variety of biological processes including cell adhesion, cellular recognition and regulation of glycoconjugates' functions (6,15,19,20,28). In melanoma cells, involvement of sialic acid residues has been well documented in determining metastatic potential (13). A lectin (WGA)-resistant phenotype and the related alteration of adhesive properties have also been shown to be due to a decrease in cell surface sialic acid content (2, 25). However, little has been known of the functional significance of sialic acid relating to other aspects of melanoma cell phenotypes.Treatment of mouse melanoma cells with 5-bromodeoxyuridine (BrdU) (18, 23) or retinoic acid (1) has been shown to result in changes in cellular sialic acid content.